Epidemiological and economic impact of pandemic influenza in Chicago: Priorities for vaccine interventions
Fig 9
Sensitivity analysis of vaccine efficacy and impact on return on investment.
Univariate sensitivity analysis for vaccine efficacy rates of 10%, 20%, 30%, 40%, 50% and 60%, and their impact on return on investment for catastrophic (Fig 9A), strong (Fig 9B) and moderate (Fig 9C) influenza pandemic scenario in the static (direct benefit) and dynamic (direct + indirect benefits) models.